3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis
持续和分阶段释放抗生素和益生菌支架的 3D 生物打印用于治疗细菌性阴道病
基本信息
- 批准号:10580042
- 负责人:
- 金额:$ 76.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-25 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:3-Dimensional3D PrintAdherenceAdverse eventAffectAftercareAgeAlginatesAnaerobic BacteriaAntibiotic TherapyAntibioticsAntifungal AgentsAppearanceAtopobium vaginaeBackBacteriaBacterial VaginosisBiological AssayBiomedical EngineeringCalibrationCell LineCellsClinicalClinical ResearchClinical TrialsComplexComputer ModelsDataDevelopmentDevicesEpithelial CellsEpitheliumEquilibriumExperimental ModelsFemaleFormulationGardnerellaGardnerella vaginalisGelatinGoalsGrowthHIVHealthHistopathologyHumanIn VitroInfectionInfertilityInflammation MediatorsInvestigationKineticsLactobacillusLinkMeasurementMeasuresMedicineMetronidazoleMicrobeModelingMucous body substanceMusOralOutcomePelvic Inflammatory DiseasePhasePre-Clinical ModelPrevotellaPrintingProbioticsProcessProliferatingPropertyReapplicationRecordsRecurrenceRegimenRetreatmentSerumSexually Transmitted DiseasesSiliconesSymptomsSyndromeTestingTherapeuticTherapeutic AgentsTissuesTopical AntibioticTopical applicationTreatment EfficacyTreatment ProtocolsTreatment outcomeUterusVaginaWomanWorkadverse pregnancy outcomeagedbioprintingco-infectioncytotoxicitydelivery vehicledesigndysbiosisengineering designexperienceexperimental studyfabricationgut healthhigh riskimprovedimproved outcomein vitro Modelin vitro testingin vivomathematical modelmicrobialmicrobicidemouse modelmultidisciplinarynovelpathogenpre-clinicalpredictive modelingpreventprobiotic therapyprototypereduce symptomsreproductivereproductive tractscaffoldvaginal lactobacillivaginal microbiomevirtual
项目摘要
PROJECT SUMMARY
Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome that affects ~29% of reproductive age women
and is linked with higher risks of adverse pregnancy outcomes, postsurgical infections, and sexually transmitted
infections. While lactobacilli typically dominate the healthy vagina, BV is characterized by low lactobacilli levels
and an overgrowth of diverse anaerobic bacteria, most often including Gardnerella and Prevotella. Current oral
or topical antibiotic treatments alleviate symptoms in 80% of women, at least temporarily. However, most women
will experience a recurrence of BV within one-year post-treatment. A recent clinical study showed that a vaginal
probiotic treatment regimen (with Lactobacillus crispatus), used following a vaginal course of antibiotics
(metronidazole), significantly improved long-term treatment efficacy. Unfortunately, current topically-applied
formulations require repeated administrations (once to twice daily), which can hinder female convenience and
adherence to treatment, particularly when undergoing multiple weeks of treatment (required to administer both
antibiotic and probiotics).
In this project we will use 3D printing and computational modeling, iteratively enabled by functional investigation
of prototype scaffolds in vitro and in vivo, to design long-acting products that sustain therapeutic delivery, while
enabling phased-delivery of antibiotics and probiotics to the female reproductive tract. Our team brings together
female reproductive tract-specific expertise in delivery vehicle design, computational modeling, and preclinical
BV models. The ultimate goal is to use 3D-bioprinting to incorporate different device compartments, which
sequentially release antibiotics that target anaerobic overgrowth, followed by live probiotics that restore balance
back in favor of vaginal lactobacilli. In Aim 1, we will design and characterize 3D-printed silicone scaffolds that
sustain antibiotic-only delivery. Aim 2 will design and evaluate 3D-printed silicone and gelatin alginate
composites that sequentially release antibiotics followed by probiotics, providing a “1-2 punch” strategy to kill BV
bacteria and provide a ‘healthy’ Lactobacillus alternative. Each aim will focus first on a materials-based
characterization of Met-containing silicone (1A) or Met-silicone probiotic-gelatin alginate composites (2A).
Measurements from in vitro release experiments will be used to develop and test computational models that
predict the delivery of antibiotic (1B) or dual agents (2B) in a “virtual female reproductive tract” and ultimately in
a mouse co-infection model. We will evaluate Met-silicone (1C) and Met-silicone probiotic-gelatin alginate
composites (2C) for cytotoxicity to the vaginal epithelium and ability to stimulate soluble proinflammatory
mediators and downstream histopathology. In our mouse model, we will measure levels of viable Gardnerella
and Prevotella recovered from vaginal and uterine tissues following treatment with blank or active agent-
containing 3D-printed scaffolds. If successful, this project will support the development of multipurpose platforms
to prevent and treat BV as well as other female reproductive tract applications.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hermann Frieboes其他文献
Hermann Frieboes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hermann Frieboes', 18)}}的其他基金
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis
持续和分阶段释放抗生素和益生菌支架的 3D 生物打印用于治疗细菌性阴道病
- 批准号:
10420527 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis
了解宿主-微生物组-治疗三联体:设计替代阴道内给药平台治疗细菌性阴道病的意义
- 批准号:
10652467 - 财政年份:2019
- 资助金额:
$ 76.74万 - 项目类别:
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis
了解宿主-微生物组-治疗三联体:设计替代阴道内给药平台治疗细菌性阴道病的意义
- 批准号:
10443781 - 财政年份:2019
- 资助金额:
$ 76.74万 - 项目类别:
相似海外基金
Study on the use of 3D print models to improve understanding of geomorphic processes
研究使用 3D 打印模型来提高对地貌过程的理解
- 批准号:
22K13777 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
3D print-on-demand technology for personalised medicines at the point of care
用于护理点个性化药物的 3D 按需打印技术
- 批准号:
10045111 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Grant for R&D
Regenerative cooling optimisation in 3D-print rocket nozzles
3D 打印火箭喷嘴的再生冷却优化
- 批准号:
2749141 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Studentship
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
- 批准号:
548945-2019 - 财政年份:2021
- 资助金额:
$ 76.74万 - 项目类别:
College - University Idea to Innovation Grants
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
- 批准号:
548945-2019 - 财政年份:2020
- 资助金额:
$ 76.74万 - 项目类别:
College - University Idea to Innovation Grants
Administrative Supplement for Equipment: 6-axis Positioner to Improve 3D Print Quality and Print Size
设备管理补充:用于提高 3D 打印质量和打印尺寸的 6 轴定位器
- 批准号:
10801667 - 财政年份:2019
- 资助金额:
$ 76.74万 - 项目类别:
SBIR Phase II: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第二阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
- 批准号:
1738138 - 财政年份:2017
- 资助金额:
$ 76.74万 - 项目类别:
Standard Grant
Development of "artificial muscle' ink for 3D print of microrobots
开发用于微型机器人3D打印的“人造肌肉”墨水
- 批准号:
17K18852 - 财政年份:2017
- 资助金额:
$ 76.74万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
I-Corps: Nanochon, a Commercial Venture to 3D Print Regenerative Implants for Joint Reconstruction
I-Corps:Nanochon,一家商业企业,致力于 3D 打印再生植入物进行关节重建
- 批准号:
1612567 - 财政年份:2016
- 资助金额:
$ 76.74万 - 项目类别:
Standard Grant
SBIR Phase I: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第一阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
- 批准号:
1621732 - 财政年份:2016
- 资助金额:
$ 76.74万 - 项目类别:
Standard Grant